Actively Recruiting
Comparison of Conventional and Cooled Radiofrequency of the Genicular Nerves in Patients With Chronic Knee Pain
Led by Ziekenhuis Oost-Limburg · Updated on 2023-05-24
400
Participants Needed
15
Research Sites
216 weeks
Total Duration
On this page
Sponsors
Z
Ziekenhuis Oost-Limburg
Lead Sponsor
B
Belgium Health Care Knowledge Centre
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic knee pain remains a disabling disease despite current treatment strategies. There is an increase in the prevalence of osteoarthritis (OA) of the knee in the general population, presently affecting approximately 450,000 individuals in Belgium. A total knee replacement is a viable alternative for severe knee OA that does not respond to conservative therapy. Unfortunately, up to 53% of patients who undergo a total knee replacement develop persistent post-surgical pain (PPSP). There is currently no effective therapy for PPSP. A radiofrequency (RF) treatment applies high frequency current on the nerve responsible for pain conduction, resulting in an interruption of the transmission of pain. This can be applied to the nerves innervating the knee joint - the superolateral, superomedial and inferomedial genicular nerves - and could be an alternative, minimally invasive treatment for patients with knee OA who fail conservative treatments and for patients with PPSP. Data from the recent literature indicates that this treatment leads to a reduction of pain intensity and could result in an improvement of knee function, of the psychological state of the individual, and finally in an increase in health-related quality of life. Furthermore, RF of the genicular nerves could help avoid or delay a total knee replacement therefore potentially contributing to cost reduction. Both cooled and conventional RF treatments are reported in the literature to improve pain. The use of water to cool the RF electrodes results in an increased lesion size by removing heat from adjacent tissue, allowing power delivery to be increased. As a consequence, cooled RF could result in a higher chance of success and longer duration of effect. Until now, the studies performed on cooled RF are industry initiated and a direct comparison between conventional, cooled and a sham procedure is lacking. The aim of the COGENIUS trial is to investigate the effect of the two types of RF treatment on individuals experiencing chronic knee pain that is resistant to conservative treatments. For this purpose, the efficacy and cost-effectiveness of cooled and conventional RF will be compared to a sham procedure in patients suffering from knee OA and PPSP after total knee replacement.
CONDITIONS
Official Title
Comparison of Conventional and Cooled Radiofrequency of the Genicular Nerves in Patients With Chronic Knee Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed written informed consent before any study assessments
- Adults aged 18 years or older
- Chronic anterior knee pain lasting more than 12 months that is moderate to severe (NRS > 4 on most or all days) for the affected knee
- Knee pain unresponsive to at least 12 months of conventional treatments including physiotherapy, pain medication, and intra-articular corticosteroid injections
- For osteoarthritis patients: Radiologic confirmation of knee OA grade 2, 3, or 4 within 12 months prior to screening
- For patients with persistent post-surgical pain after total knee arthroplasty: Negative orthopaedic work-up
You will not qualify if you...
- Local or systemic infection (bacteraemia)
- Inflammatory arthritis or systemic inflammatory disease causing knee pain
- Intra-articular injections in the affected knee within 3 months prior to procedure
- Pregnant, nursing, or planning pregnancy before study intervention
- Chronic widespread pain
- Unstable psychosocial disorder
- Allergies to products used during procedure (lidocaine, propofol, chlorhexidine)
- Uncontrolled coagulopathy or immune suppression
- Participation in another clinical trial within 30 days before consent
- Implanted neurostimulator
- Current radicular pain in the affected leg
- Previous conventional or cooled radiofrequency treatment of the affected knee
- Bilateral chronic knee pain unresponsive to conventional treatments
- Planned total knee arthroplasty in the near future
- Unable or unwilling to complete study questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
UZ Antwerpen
Antwerp, Belgium, 2650
Actively Recruiting
2
AZ Klina
Brasschaat, Belgium, 2930
Active, Not Recruiting
3
ULB Erasme
Brussels, Belgium, 1070
Actively Recruiting
4
UCL Saint-Luc
Brussels, Belgium, 1200
Active, Not Recruiting
5
Ziekenhuis Oost-Limburg AV
Genk, Belgium, 3600
Actively Recruiting
6
AZ Maria Middelares
Ghent, Belgium
Actively Recruiting
7
Jessa Ziekenhuis
Hasselt, Belgium, 3500
Actively Recruiting
8
AZ Groeninge
Kortrijk, Belgium, 8500
Active, Not Recruiting
9
UZ Leuven
Leuven, Belgium, 3000
Actively Recruiting
10
CHR de la Citadelle
Liège, Belgium, 4000
Actively Recruiting
11
CHU Liège
Liège, Belgium, 4000
Active, Not Recruiting
12
AZ Delta
Roeselare, Belgium, 8800
Actively Recruiting
13
AZ Turnhout
Turnhout, Belgium, 2300
Actively Recruiting
14
Rijnstate
Arnhem, Netherlands, 6815 AD
Active, Not Recruiting
15
MUMC
Maastricht, Netherlands, 6229 HX
Actively Recruiting
Research Team
J
Jan Van Zundert
CONTACT
C
Charlotte Claes
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here